Key result
Baseline HbA1c >8.0% is linked to higher all-cause and CV mortality, specifically in overweight patients.
Cohort (n=6,220)
No
Answers are grounded in this paper and cite their sources.
Objective This study aims to evaluate the relationship between a single measurement at baseline of body mass index (BMI), glycated hemoglobin (HbA1c) and subsequent clinical outcomes in patients with type 2 diabetes mellitus (T2DM). Method Patients with T2DM were recruited from an outpatient diabetes clinic in a single large teaching hospital in Kingston upon Hull, UK. At baseline, demographics and HbA1c were recorded. Patients were categorized by BMI: normal weight (18.5–24.9 kg/m 2 ), overweight (25–29.9 kg/m 2 ), and obese (>30 kg/m 2 ). Multivariable Cox regression models that included demographic, risk factors, and comorbidities were separately constructed for all-cause, cardiovascular, cancer and sepsis-related mortality, using four groups of HbA1c (<6%, 6.0–6.9%, 7.0–7.9%, and >8%). Results In total, 6220 patients with T2DM (median age 62 years, 54% male) were followed for a median of 10.6 years. HbA1c levels >8.0% were associated with increased risk of all-cause mortality and cardiovascular death. However, this increased risk was not consistent across the weight categories and reached statistical significance only in overweight patients (BMI 25–29.9 kg/m 2 ). Conclusions In a large cohort of patients with T2DM elevated HbA1c levels at baseline did not consistently predict increased risk of all-cause and cardiovascular mortality across the different BMI categories.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2020) conducted a cohort in Type 2 diabetes mellitus (n=6,220). Baseline glycated hemoglobin (HbA1c >8.0%) stratified by body mass index (BMI) vs. Lower HbA1c groups (<6%, 6.0-6.9%, 7.0-7.9%) across BMI categories (normal weight, overweight, obese) was evaluated on All-cause, cardiovascular, cancer, and sepsis-related mortality. Baseline HbA1c >8.0% was associated with increased all-cause and cardiovascular mortality, reaching significance only in overweight patients over 10.6 years.
Synapse has enriched 10 related papers. Consider them for comparative context: